Table 2 Means and confidence intervals obtained in sub-study 1.
HAM-D | Baseline (n = 40) | 1-month follow-up (n = 26;) | 6-months follow-up (n = 15) |
|---|---|---|---|
3.60 [1.77–5.43] | 1.75 [0.38–3.12] | 0.60 [0–1.35] | |
CAPE | |||
Total frequency score | 63.3 [59.6–67] | 56.2 [49.4–63] | 62 [56–68] |
Total distress score | 39.2 [31.6–46.9] | 35.6 [27.9–43.3] | 37.1 [23.2–51] |
Positive symptoms frequency | 26.8 [25.1–28.4] | 26 [24.7–27.4] | 26.9 [23.8–30] |
Positive symptoms distress | 10 [7.4–12.6] | 8.2 [6.4–10.1] | 9.4 [4.7–14.2] |
Depression symptoms frequency | 13.5 [12.5–14.4] | 12.7 [12–13.5] | 12.8 [11.3–14.2] |
Depression symptoms distress | 11.5 [9.3–13.5] | 11.2 [8.7–13.6] | 10.8 [6.8–14.9] |
Negative symptoms frequency | 23 [21.4–24.7] | 21.5 [19.9–23.1] | 22.2 [20.3–24.1] |
Negative symptoms distress | 17.7 [14.2–21.2] | 16.2 [11.8–20.5] | 16.8 [10.7–22.8] |
SCL-90-R SOM | 0.57 [0.39–0.75] | 0.45 [0.34–0.57] | 0.91 [0.50–1.32] |
O-C | 0.63 [0.43–0.84] | 0.44 [0.24–0.64] | 0.82 [0.42–1.21] |
I-S | 0.60 [0.43–0.78] | 0.41 [0.22–0.61] | 0.67 [0.25–1.08] |
DEP | 0.58 [0.38–0.77] | 0.40 [0.21–0.60] | 0.70 [0.36–1.04] |
ANX | 0.42 [0.28–0.56] | 0.24 [0.17–0.31] | 0.58 [0.30–0.85] |
HOS | 0.52 [0.32–0.73] | 0.22 [0.12–0.31] | 0.49 [0.23–0.75] |
PHOB | 0.07 [0.01–0.13] | 0.10 [0.03–0.17] | 0.32 [0.1–0.54] |
PAR | 0.40 [0.26–0.54] | 0.35 [0.21–0.49] | 0.65 [0.22–1.07] |
PSY | 0.23 [0.12–0.33] | 0.13 [0.07–0.19] | 0.42 [0.11–0.73] |
GSI | 0.48 [0.34–0.62] | 0.33 [0.22–0.44] | 0.64 [0.34–0.93] |
PSDI | 28.3 [22.1–34.5] | 23.51 [17.7–29.3] | 42.5 [25.1–60] |
PST | 1.35 [1.21–1.5] | 1.17 [1–1.28] | 1.26 [1.07–1.45] |
AAQ-II | 19.9 [17.3–22.6] | 18.2 [15.5–20.8] | 18.8 [15.6–22.1] |
TCI-R-67 NS | 22.4 [20.8–24.1] | 21.8 [20.1–23.5] | 22.4 [19.2–25.7] |
HA | 18.7 [17–20.5] | 16.6 [15.2–18.1] | 17.7 [16.3–19.1] |
RD | 29.2 [26.9–31.4] | 30.6 [29–32.2] | 30.5 [27.7–33.3] |
PER | 25.3 [23.8–26.9] | 22.5 [20.3–24.8] | 24.2 [22–26.5] |
SELFD | 30 [28.8–32.4] | 32.3 [30.5–34.2] | 31.2 [29.1–33.3] |
COOP | 32 [30.6–33.4] | 32 [30–34] | 31.8 [29.5–34.1] |
ST | 20.7 [18.4–23] | 21.4 [17.6–25.1] | 23.2 [17.8–28.7] |
SF-36 PF | 97.7 [96–99.5] | 98.4 [97.2–99.7] | 97.9 [95.8–100] |
RP | 87.5 [78.2–96.7] | 96.1 [88.2–104] | 87.8 [72.3–103.3] |
BP | 78 [69.7–86.2] | 89.8 [81.7–97.8] | 84.6 [70.9–98.3] |
GH | 77.5 [71.9–83] | 82.5 [77.5–87.5] | 72.4 [64.1–80.8] |
VIT | 62 [55.6–68.3] | 70 [64.5–75.4] | 70.7 [62–79.4] |
SF | 81.2 [74–88.4] | 88.8 [81.2–96.5] | 89.1 [79–99.2] |
RE | 72.1 [59.3–84.8] | 83.3 [70–96.6] | 94 [87.1–101] |
MH | 69.3 [63.6–75] | 74.6 [69.8–79.4] | 74.4 [65.6–83.1] |
WHOQOL-Bref | 17.4 [15.1–19.6] | 20.67 [17.9–23.4] | 21.4 [18.1–24.7] |
